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Abstract 
Autism spectrum disorder (ASD) is one of the most prevalent neurodevelopmental conditions 
worldwide. There is growing awareness that ASD is highly comorbid with gastrointestinal 
distress and altered intestinal microbiome, and that host-microbiome interactions may contribute 
to the disease symptoms. However, the paucity of knowledge on gut-brain axis signaling in 
autism constitutes an obstacle to the development of precision microbiota-based therapeutics in 
ASD. To this end, we explored the interactions between intestinal microbiota, gut physiology 
and social behavior in a BTBR T+ Itpr3tf/J mouse model of ASD. Here we show that a reduction 
in the relative abundance of very particular bacterial taxa in the BTBR gut – namely, bile-
metabolizing Bifidobacterium and Blautia species, -  is associated with deficient bile acid and 
tryptophan metabolism in the intestine, marked gastrointestinal dysfunction, as well as impaired 
social interactions in BTBR mice. Together these data support the concept of targeted 
manipulation of the gut microbiota for reversing gastrointestinal and behavioral symptomatology 
in ASD, and offer specific plausible targets in this endeavor. 
 
Key words  
Autism, BTBR mouse, gut microbiota, intestinal permeability, intestinal transit, bile acids, 
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Highlights  
 BTBR mice display a reduced abundance of bile-metabolizing Bifidobacterium and 
Blautia bacterial species in the intestine 
 BTBR mice demonstrate deficient bacterial metabolism of bile moieties in the gut 
 Changes in the gut microbiota are associated with marked gastrointestinal distress and 
reduced sociability in BTBR mice 
 
 
Research in Context  
There is growing awareness that the gut microbiome may contribute to gastrointestinal and 
behavioral symptomatology of autism spectrum disorder (ASD). However, the exact mechanisms 
by which intestinal bacteria can affect gut-brain axis signaling in autism are as yet poorly 
understood. Here we explore interactions between intestinal microbiota, gut physiology and 
behavior in a mouse model of ASD. We show that a reduction in the abundance of particular 
intestinal bacteria in “autistic” mice is associated with gastrointestinal distress and social 
behavior deficits. This work supports the concept of targeting the gut microbiota for reversing 
gastrointestinal symptoms in ASD, and identifies specific plausible targets for microbiota-based 
interventions.  
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Introduction 
Autism spectrum disorder (ASD) is one of the most serious neurodevelopmental conditions 
worldwide, affecting on average 1 in 150 children (Lyall et al., 2017). The hallmarks of ASD 
include impaired social communication skills and repetitive behaviors, frequently co-occurring 
with intellectual disability (Association, 2013). There are limited treatment options for ASD 
symptoms, and thus there is a great need to develop strategies that would improve the quality of 
life in ASD subjects. More recently, the gut microbiome has emerged as a novel important player 
and therapeutic target in autism (Vuong and Hsiao, 2017). Intestinal bacteria can orchestrate a 
range of gastrointestinal (GI) functions (Sommer and Backhed, 2013), and therefore are poised 
to affect gut-brain axis signaling in ASD. Animal studies have demonstrated that the gut 
microbiota plays a crucial role in anxiety (Neufeld et al., 2011), cognitive performance 
(Desbonnet et al., 2015), repetitive behaviors (Desbonnet et al., 2014) and social 
communications (Buffington et al., 2016; Sherwin et al., 2017). There is a growing body of 
evidence that ASD subjects display substantial alterations in microbiota composition, along with 
marked symptoms of GI distress, including changes to bowel habits, increased intestinal 
permeability, bloating and abdominal pain (Angelis et al., 2013; D'Eufemia et al., 1996; Kang et 
al., 2013; Luna et al., 2016; McElhanon et al., 2014; Tomova et al., 2015). In a recent small 
open-label clinical study, transplantation of standardized human gut microbiota to ASD-
diagnosed children induced an improvement of GI function, as well as a reduction of behavioral 
ASD scoring (Kang et al., 2017). However, we do not yet know whether alterations in the gut 
microbiota in autism can in itself affect either behavioral or gastrointestinal symptoms of ASD.  
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Identification of specific bacterial taxa and associated bacterial metabolites that can trigger 
changes in GI physiology and modulate the onset of autistic behaviors is thus an important quest 
in the search for precision microbiota-based therapeutics in ASD (Gilbert et al., 2013). 
Preclinical research is crucial in this endeavor (Hsiao et al., 2013; Kumar and Sharma, 2016). 
The BTBR T+ Itpr3tf/J mouse strain is one of the most widely used models of ASD. Similar to 
humans, these animals display robust deficits in social interactions and enhanced engagement in 
repetitive behaviors (Meyza et al., 2013; Moy et al., 2007). Moreover, the autistic-like behavior 
of BTBR mice is largely driven by multiple genetic alterations (Meyza and Blanchard, 2017), but 
is also sensitive to environmental influences, such as dietary intervention (Ruskin et al., 2013). 
Changes to a few bacterial taxa have also been recently reported in the BTBR intestine (Coretti 
et al., 2017; Klein et al., 2016; Newell et al., 2016). Together, these findings strengthen the 
utility of the BTBR strain in understanding dysfunctional microbiota-gut-brain signaling in ASD. 
To this end, we characterized GI physiology in BTBR mice and found substantial abnormalities 
in both intestinal barrier function and intestinal transit. We identified changes in bile acid and 
tryptophan metabolism as putative mechanisms underlying GI dysfunction in these animals. We 
further associated the observed changes in GI physiology with a reduction in the abundance of 
certain bacterial taxa in the BTBR microbiota.  
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Materials and Methods 
Animals C57BL/6J (Harlan, UK) and BTBR T+ Itpr3tf/J (The Jackson Laboratory, US) adult 
male mice were group housed under a 12h light-dark cycle; standard rodent chow and water 
were available ad libitum. All experiments were performed in accordance with European 
guidelines following approval by University College Cork Animal Ethics Experimentation 
Committee. 
Study design Three independent cohorts participated in the study (Fig S1). Detailed information 
on procedures with references is provided in Supplemental Methods. 
Behavioral assessment Social behavior was analyzed in the three-chamber, social transmission 
of food preference and resident-intruder tests; compulsive behavior in the marble burying and 
self-grooming tests; anxiety-like behavior in the open field and elevated plus maze tests; 
depressive-like behavior in the forced swim test; cognitive performance in the novel object 
recognition test. 
Plasma corticosterone in response to an acute stressor Corticosterone levels were measured in 
plasma prior to (baseline) and after the onset of the forced swim test. 
Fecal water content Water content in feces was calculated as the difference in weight after 
desiccation of fecal pellets. 
Whole intestinal transit A test mouse was administered with carmine dye by oral gavage; the 
latency for the excretion of the first red-colored fecal pellet was recorded. 
Colonic transit An artificial pellet was inserted into the proximal end of the isolated colon, and 
the spontaneous propagation of the pellet in anterograde direction was video recorded. The 
latency to initiate the propagation and the velocity of propagation were scored.  
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Intestinal permeability Intestinal tissue samples were mounted into the Ussing chambers. Short-
circuit current (Isc) was recorded in a zero voltage clamp mode; transepithelial electrical 
resistance (TEER) was measured by discharging a 2 mV pulse. 4kDa FITC-dextran was added to 
the mucosal chamber at a final concentration of 2.5 mg/mL; 200 μL samples were collected from 
the serosal chamber every 30 min for the following 3 h. 
Myenteric plexus morphology Myenteric plexus (MP) of distal colon was subjected to 
immunoflourescent staining against choline acetyltransferase (ChAT), HuC/HuD and nNOS. To 
analyze the morphology of MP, the following parameters were calculated in anti-ChAT stained 
tissues: the area occupied by MP; the mean thickness and the contact ratio of MP; the mean Feret 
diameter of interganglionic space. The numbers of HuC/HuD- and nNOS-positive myenteric 
neurons were quantified per visual field. 
Tryptophan, kynurenine and serotonin levels Serotonin was measured in intestinal tissue 
samples by HPLC coupled to electrochemical detection. Kynurenine and tryptophan 
concentrations were determined in plasma by HPLC coupled to ultraviolet (230 nm) and 
fluorescent (254 nm excitation and 404 nm emission wavelengths) detection, accordingly. 
Gene expression analysis Total RNA was extracted from the intestinal tissues and the front lobe 
of the liver with RNeasy Plus Universal Mini kit, and from the right hippocampus with 
mirVana™ miRNA Isolation Kit. Genes of interest were amplified with real-time RT-PCR using 
TaqMan probes (Table S1). Data were analyzed with the comparative cycle threshold method (2-
ΔΔCt) and presented as a fold change vs. C57BL/6 group.  
Bile acids levels in plasma and fecal material Fecal and plasma bile acids and salts were 
extracted following addition of deuterated internal standards (IS). Extracted acids were 
resuspended in 50% methanol, injected in triplicate and assessed in negative electrospray mode 
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through a C18 Acquity column using a LCT Premier mass spectrometer (Waters Corp).  
Assessment of extraction efficiency was performed using IS, and samples were quantified by 
standard curve construction for individual bile moieties using targetlynx software (Waters). 
Microbiota composition and short chain fatty acids analysis in the cecal content DNA was 
extracted using the QIAmp Fast DNA Stool Mini Kit coupled with an initial bead-beating step. 
The V3-V4 hypervariable region of the 16S rRNA gene was amplified and prepared for 
sequencing as outlined in the Illumina 16S Metagenomic Sequencing Library Protocol. Samples 
were sequenced at Clinical-Microbiomics (Copenhagen, Denmark) on the Illumina MiSeq 
platform using a 2x300 bp kit. Reads were assembled, processed and analyzed following the 
pipeline, described in Supplemental Methods. Short chain fatty acids (SCFAs) were measured by 
gas chromatography, using a Varian 3500 GC flame-ionization system fitted with a with a ZB-
FFAP column. 
Statistical analysis Normally distributed data are presented as mean ± SEM; unpaired two-tailed 
t-test and mixed-design ANOVA were applied to analyze the difference between groups. Non-
parametric datasets, as well as discrete data, are presented as median (IQR). Mann-Whitney test 
was used for between-group comparisons. Spearman’s rank correlation coefficient was employed 
for the correlation analysis in the pooled datasets. A p value <0.05 was deemed significant in all 
cases.  
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IPT
 9 
Results 
BTBR mice display marked changes in the intestinal microbiota The 16S 
sequencing revealed a substantial reduction in the bacterial species diversity in the BTBR cecum 
(Fig 1a). Principal coordinate analysis showed a clear separation of BTBR and C57BL/6 
microbiotas (Fig 1b). We detected 9 phyla, 23 families and 41 bacterial genera in C57BL/6 and 
BTBR mice (Table S2). At the phylum level, BTBR mice displayed a distinct shift towards an 
increase in Bacteroidetes and a decrease in Firmicutes; these are two major bacterial phyla 
altogether comprising more than 90% of murine intestinal microbiota (Fig 1c). The bloom in 
Bacteroidetes was mainly driven by an increase in S24-7 uncultured bacterium, a dominant 
genus of S24-7 family. Interestingly, this seems to have happened at the expense of minor 
Bacteroidetes genera such as Odoribacter, Parabacteroides, RC9 gut group and Rikenella, 
which all showed a reduction in relative abundance. A decrease in Firmicutes was largely driven 
by Lachnospiraceae family, in particular Blautia bacteria, but also Lachnospiraceae_Incertae 
Sedis and Coprococcus. BTBR mice also displayed an increase in Akkermansia, Bacteroides and 
Bilophila genera, as well as a reduction in Bifidobacterium and Desulfovibrio (Table S2). With 
such a prominent shift in the microbiota composition, it was perhaps not surprising that BTBR 
mice also displayed significant changes in the SCFAs levels in the gut lumen (Fig 1d). Overall, 
BTBR mice seem to have a very robust phenotype of the gut microbiota. For example, a similar 
increase in Akkermansia and a reduction in Bifidobacterium numbers in the BTBR cecum were 
also shown in previous reports (Klein et al., 2016; Newell et al., 2016). In the fecal material of 
BTBR mice, Coretti et al. found a slightly different pattern of changes in the microbiota 
composition (Coretti et al., 2017); however, care should be taken when comparing cecal and 
fecal bacterial communities.  
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BTBR mice show delayed intestinal transit Among GI comorbidities associated with 
ASD, changes in bowel habits, in particular constipation, are the most prevalent (McElhanon et 
al., 2014). Hence, we examined intestinal motility, and found that whole intestinal transit was 
significantly delayed in BTBR mice (Fig 2a). Further, BTBR mice displayed an elongated colon 
and decreased fecal water contents (Fig 2b-c), both observations suggesting that the propagation 
of fecal matter along the colon was substantially slowed. . The follow-up ex vivo analysis of 
colonic motility provided clear evidence of impaired transit in the BTBR large intestine. Indeed, 
it took almost twice as long to initiate spontaneous propagation of the pellet along the colon, and 
there was a trend towards a reduction in the velocity of oral-to-anal propulsion in BTBR mice 
(Fig 2d). Measuring small intestinal transit in BTBR mice would be of interest for the future 
studies, particularly bearing in mind that impaired small intestinal motility was previously 
reported in a rat model of ASD (Kim et al., 2013).  
Impaired serotonin production in the BTBR intestine The release of mucosal 
serotonin (5-HT) triggers intestinal peristalsis (Heredia et al., 2013). To address the potential 
contribution of 5-HT metabolism to the delayed transit in the BTBR intestine, we assessed 5-HT 
availability in colonic and ileal tissue samples.  We observed a 50% reduction in 5-HT tissue 
levels in both small and large intestine of BTBR mice, which was coupled with a down-
regulation of Tph1 and an up-regulation of Sert gene expression (Fig 2e-f). Tph1 activity 
determines the amount of 5-HT which is produced from dietary tryptophan and released from 
enterochromaffin cells, while Sert controls the rate of 5-HT re-uptake and consequent breakdown 
in enterocytes (Mawe and Hoffman, 2013). In line with the gene expression data, the ratio 
between 5-HIAA (the major metabolite of 5-HT) and 5-HT tended to be increased in the BTBR 
intestine (Fig 2e-f). Together, these findings suggest reduced bioavailability of 5-HT in the 
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BTBR gut due to a decrease in 5-HT synthesis and an increase in 5-HT breakdown. Alternatively 
to 5-HT, dietary tryptophan in the intestine can be metabolized along the kynurenine route. Ido1 
and Tdo2 are two rate-limiting enzymes in this metabolic pathway. We found that the expression 
levels of both Ido1 and Tdo2 genes were markedly down-regulated in the BTBR colon.  
Interestingly, opposite changes in Ido1 and Tod2 genes were observed in the small intestine of 
BTBR mice (Fig 2e-f).  
Intestinal transit and serotonin levels correlate with the abundance of certain 
bacterial taxa Gut microbes, in particular spore-forming clostridia, have been shown to 
regulate 5-HT metabolism in the GI tract (Yano et al., 2015). To this end, we investigated 
whether observed changes in the intestinal transit and 5-HT levels in the gut were associated 
with alterations in the abundance of any particular bacterial taxa. We found that both 5-HT tissue 
levels and intestinal transit rate were strongly and positively correlated with the relative 
abundance of Firmicutes bacteria; this correlation was mainly driven by the Blautia genus of the 
Clostridiales order (Fig 2g). There were also strong correlations between the abundance of 
Blautia and Tph1, Sert and Ido1 gene expression levels (Table S3). Similar, but weaker 
associations were observed with the Lachnospiraceae Incertae Sedis genus of the same order. 
These findings confirm the importance of clostridia bacteria in the maintenance of normal 
peristalsis and 5-HT synthesis in the gut. 
BTBR mice display deficits in the development of the enteric nervous system  
Healthy motility of the GI tract relies heavily on the enteric nervous system (ENS). We thus 
aimed to investigate whether delayed colonic transit in BTBR mice could have also been 
attributed to abnormal development of motor circuits in the ENS. For this, we stained the 
myenteric plexus (MP) in distal colon against choline acetyltransferase (ChAT), which is 
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expressed in a vast majority of myenteric neurons including excitatory motor neurons, and 
against neuronal NO synthase (nNOS), which is expressed in inhibitory motor neurons of MP 
(Furness, 2000). ChAT staining showed the fine structure of MP with ganglia and 
interganglionic fibers (Fig 3a). The morphometric analysis revealed a substantial reduction in the 
spatial density of MP in BTBR mice: the area occupied by MP was decreased, while the 
interganglionic space was increased (Fig 3b). Furthermore, we found a 50% reduction in the 
numbers of inhibitory motor neurons (nNOS) and total myenteric neurons (pan-neuronal 
HuC/HuD marker) (Fig 3c-d). These data suggest an abnormal development of both excitatory 
and inhibitory motor neurons in BTBR mice. These are interesting data in the context of recent 
findings indicating that the gut microbiota is essential for the development of the ENS (Collins et 
al., 2014; Obata and Pachnis, 2016). 
BTBR mice have differential changes in epithelial permeability in small and 
large intestine Along with altered bowel habits, ASD has been associated with impaired 
intestinal barrier function (D'Eufemia et al., 1996; de Magistris et al., 2010; Fiorentino et al., 
2016). To characterize epithelial permeability in the BTBR intestine, we measured the efficacy 
of macromolecular diffusion across the epithelium ex vivo (4kDa FITC flux). In the distal ileum, 
we observed a dramatic increase in epithelial permeability in BTBR mice (Fig 4a). FITC flux 
was increased approximately two-fold at the 60 min time point and remained consistently 
elevated over the next two hours of the assay (p=0.019 for the effect of genotype, F(1;14)=7.090). 
Macromolecular permeability of intestinal epithelium is largely dependent on the proper function 
of tight junctions (TJs) (Zihni et al., 2016). Despite an increase in FITC flux, we failed to find 
substantial alterations in the gene expression levels of either TJ proteins (Cldn1, Ocln and Tjp1) 
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or proteins regulating the assembly and energy supply to TJs (Ckb, Ckm, Mylk)(Glover et al., 
2013; Shen et al., 2006)  (Fig 4b).  
Colonic tissue showed a very distinct profile of macromolecular permeability in BTBR mice (Fig 
4c). During the first 90 min of the assay, FITC flux was slightly decreased (p=0.002 for the 
time×genotype interaction, F(6;102)=9.198; p=0.003 for 60 min and p=0.057 for 90 min). 
However, during the following 90 min, FITC flux in BTBR samples substantially accelerated, 
overtaking the control group and reaching significantly higher levels by the end of the assay 
(p=0.029 for 180 min). Gene expression analysis shed some light on the biphasic response of 
FITC permeability (Fig 4d). On one hand, a marked increase in Cldn1 gene expression can 
explain a functionally “tighter” epithelium in the BTBR colon at baseline. On the other hand, a 
50% down-regulation of creatine kinase Ckb and Ckm genes suggests a reduced efficacy of 
phosphocreatine metabolic shuttle turnover, which is critically important for the maintenance of 
energy supply to TJs (Glover et al., 2013). This would favor a rapid increase in macromolecular 
permeability in BTBR samples in ex vivo conditions, when tissue specimens are exposed to 
limited oxygen and substrate supply. Furthermore, these findings suggest that the BTBR colon 
might be less resilient to any metabolic stress in vivo, such as intestinal inflammation or hypoxia. 
The epithelial mucus layer also helps to maintain the physical barrier between the gut and the 
lumen (Johansson et al., 2011). Interestingly, the expression of Muc2, a gene encoding mucin 2, 
which is the major constituent of mucus layer, was down-regulated in the large intestine of 
BTBR mice, but not in distal small intestine (Fig 4e). Despite marked alterations in FITC 
permeability, only marginal changes in ion conductance (TEER) were observed in either ileum 
or colon samples of BTBR mice (Fig 4f, left panel). Although at first glance counterintuitive, 
these findings are supported by the current model of junctional gate (Zihni et al., 2016), whereby 
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ions and molecules use different pathways to diffuse through the tight junction. TEER and 
macromolecular permeability of the intestinal epithelium can thus be differentially regulated and 
even functionally decoupled (Balda et al., 1996). 
Reduced activity of electrolyte transport in the BTBR intestine We analyzed Isc 
values in BTBR and C57BL/6 intestine as a measure of electrolyte transport across the 
epithelium. In both small and large intestine, Isc was substantially decreased in BTBR mice (Fig 
4f, right panel). This suggests either a reduction in Na+ absorption from the gut lumen and/or a 
decrease in Cl- secretion into the lumen. Interestingly, we observed a down-regulation of Slc5a1 
gene in the BTBR ileum (Fig S2a). Slc5a1 encodes apical Na+/glucose co-transporter, which is 
known to enhance intestinal Isc in the presence of luminal glucose (Berglund et al., 2001; Turner 
et al., 1997). Activation of Cl- secretion in the colon is associated with water retention in the 
lumen and, when reaching pathological levels, diarrhea (Thiagarajah and Verkman, 2012). In this 
regard, a reduction in Cl- secretion in the BTBR colon would be consistent with decreased fecal 
water contents and delayed colonic transit (Fig 2b-d). 
Intestinal permeability correlates with the abundance of certain bacterial taxa 
Gut bacteria and their metabolites can modulate intestinal barrier function (Kelly et al., 2015); 
therefore, we examined the associations between microbiota composition and intestinal 
macromolecular permeability (Table S3). Interestingly, here we observed a different correlation 
profile in comparison with the one found for intestinal transit and 5-HT metabolism. From the 
Firmicutes phylum, correlations with Blautia genus were largely lost. Instead, a strong negative 
association between the abundance of Ruminococcaceae Incertae Sedis bacteria and FITC 
permeability was observed. In Bacteroidetes, a strong positive correlation between FITC flux 
and S24-7 uncultured bacterium abundance was present. Many of these differences can be driven 
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by a unique metabolic profile of each bacterial genus, including the production of different 
biologically active compounds, such as SCFAs or indoles (Kennedy et al., 2017; Sandhu et al., 
2017).  
BTBR mice display reduced plasma bile acid levels and deficient bile acid 
signaling in the ileum Epithelial permeability data (Fig 4) clearly demonstrated functional 
differences between the colon and the ileum in BTBR mice. One of the unique features of the 
terminal small intestine is the active uptake of the bile from the intestinal lumen 
(de Aguiar Vallim et al., 2013). Primarily, bile acids (BAs) assist in the digestion of dietary 
lipids and regulate lipid metabolism. In the small intestine, they are also very important for the 
maintenance of epithelial barrier function (Gadaleta et al., 2010; Inagaki et al., 2006). Hence, we 
measured BAs in plasma and fecal matter of BTBR and C57BL/6 mice (Fig 5 and Table S4). In 
plasma, the levels of tauro-conjugated and unconjugated BAs were overall decreased in BTBR 
mice (Fig 5a). About 95% of the bile released into the gut is actively re-absorbed in distal ileum 
to ensure the complete enterohepatic circulation. Thus, a decrease in plasma BAs in BTBR mice 
could be attributed to a deficit in either BA synthesis or BA re-uptake. We did not find any 
changes in the gene expression of intestinal BA transporters (Asbt, Fabp6, Ostα) or liver BA 
transporters (Ntcp, Bsep) across the groups (Fig 5b-c). These findings rule out the BA 
malabsorption in BTBR mice. Instead, there was a trend towards a reduction in the expression of 
Cyp7a1 gene, which encodes a rate-limiting enzyme in the classical pathway of BA synthesis in 
the liver (Fig 5c). Interestingly, the expression of Cyp7b1 gene, which encodes a rate-limiting 
enzyme in the alternative pathway of BA synthesis, was up-regulated in BTBR mice. When 
absorbed in distal ileum, BAs activate the farnesoid X receptor (FXR) in enterocytes. The 
expression levels of Fxr gene, as well as its partners Rxrα and Hnf4α, were unchanged in the 
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BTBR ileum (Fig 5b). However, the downstream targets of this receptor, in particular Fgf15 and 
Nos2, were substantially down-regulated. Intestinal Fgf15 is a potent inhibitor of Cyp7a1 
expression and BA synthesis (Kong et al., 2012). Hence, it is surprising that suppression of the 
intestinal Fxr/Fgf15 signaling pathway failed to up-regulate Cyp7a1 gene expression in the liver 
of BTBR mice. On the other hand, Cyp7a1 expression can be activated by the nuclear receptors 
Pgc-1α and Ppar-γ (Duan et al., 2012; Shin et al., 2003). Similar to Cyp7a1, the expression levels 
of both Pgc-1α and Pparγ genes were decreased in the BTBR liver (Fig 5c), suggesting that 
multiple nuclear receptors are implicated in the decreased BA synthesis observed in BTBR mice.  
BTBR mice display a deficit in the microbial conversion of bile Bile that is not re-
absorbed in terminal small intestine undergoes further transformation by the intestinal microbiota 
(Joyce and Gahan, 2016). First, gut bacteria de-conjugate BAs from taurine and glycine. Second, 
unconjugated primary BAs (cholic acid (CA), chenodeoxycholic acid (CDCA) and muricholic 
acid (MCA) in mice) are processed into secondary BAs, such as deoxycholic acid (DCA), 
lithocholic acid (LCA) and ursodeoxycholic acid (UDCA). In the fecal matter of BTBR mice, we 
observed a remarkable increase in all conjugated BAs, for both primary and secondary 
conjugates (Fig 5d, right panel). Further, we saw a significant reduction in secondary bile acid 
LCA, with a similar trend in DCA and UDCA (Fig 5d, left panel). Moreover, the ratio between 
secondary and primary unconjugated BAs was significantly decreased in BTBR mice (Fig S3). 
These data indicate that the BTBR microbiota has a reduced capacity to metabolize host bile. 
Changes in the gut microbiota are associated with a robust autistic-like 
behavioral phenotype We characterized the ASD-relevant behavioral phenotype in BTBR 
mice (Fig 6). In agreement with previous reports (Meyza et al., 2013), BTBR mice demonstrated 
impaired social interactions (a-c); enhanced engagement in repetitive behaviors (e-f), as well as 
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increased anxiety levels (h-k). Here we found decreased levels of social behavior-related 
hormone oxytocin in BTBR plasma (d). Further, BTBR mice displayed higher baseline levels of 
the stress hormone corticosterone, as well as elevated corticosterone values at the peak of the 
acute stress response and during the subsequent recovery phase (Fig 6l, p<0.05 for the effect of 
genotype, F(1;16)=8.193). Despite this hyper-corticosterone phenotype, BTBR mice had smaller 
adrenal glands, and increased expression of the glucocorticoid receptor gene in the hippocampus 
(Fig 6m-n). Interestingly, the expression of Cyp11a1, a gene encoding the first rate-limiting 
enzyme in the production of corticosterone, was substantially up-regulated in the distal ileum of 
BTBR mice (Fig S2b). Taken on its own, this transcriptional shift does not necessarily implicate 
an increase in intestinal hormonal levels. However, if local production of corticosterone was 
elevated in the BTBR ileum, this could explain increased levels of circulating hormone (Fig 6l) 
(Mukherji et al., 2013). This could also affect the GI physiology in BTBR mice including an up-
regulation of Tdo2 gene in distal ileum (Fig 2f, see also Discussion). 
Correlation analysis between the relative abundance of bacterial taxa and behavioral scores 
showed an impressively strong association between the gut microbiota and the behavioral 
phenotype (Fig 7). Rikenella, Parabacteroides, Odoribacter, Desulfovibrio, Blautia and 
Bifidobacterium species (all reduced in abundance in BTBR mice) were positively correlated 
with the social behavior scores and negatively correlated with the repetitive behaviors and 
anxiety phenotype. For the S24-7 family, Bilophila and Bacteroides species (all increased in 
abundance in BTBR mice), a negative association with sociability levels and a positive 
association with compulsive and anxiety-like behaviors was observed (Fig 7). Given the tight 
interactions between the gut microbiota and GI functions (Table S3), it is perhaps not surprising 
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that behavioral scores were also associated with changes in the intestinal serotonin levels and 
other GI parameters assessed (Fig S4). 
 
 
 
  
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IPT
 19 
Discussion 
The BTBR mouse strain is a very popular and useful animal model of ASD, with a robust 
autistic-like behavioral phenotype (Meyza et al., 2013). Here we show that social behavior 
deficits in BTBR mice are associated with marked GI distress, evidenced by changes in intestinal 
permeability, transit and the ENS morphology, as well as with altered microbiota composition. 
BTBR mice displayed profound changes in the cecal microbiota, with 18 out of 44 identified 
bacterial genera being differentially altered (Table S2). These included bacterial taxa that have 
previously been shown to be important for host health, and some of them associated with ASD: 
Akkermansia, Bifidobacterium, Blautia, Desulfovibrio, Bilofila, etc (Kang et al., 2017; Vuong 
and Hsiao, 2017). A significant reduction in the relative abundance of Blautia and 
Bifidobacterium genera are of particular interest with respect to GI physiology in BTBR mice. 
Indeed, Blautia bacteria belong to the Clostridiales order, representatives of which have been 
shown to modulate 5-HT metabolism in the host by increasing the expression of Tph1 in the gut, 
activating 5-HT synthesis and accelerating GI motility (Yano et al., 2015). Furthermore, Blautia 
and Bifidobacterium species are involved in the transformation of host bile. Bifidobacterium, 
along with Lactobacillus and a few other taxa, express bile salt hydrolase enzymes, which carry 
out de-conjugation of BAs from taurine or glycine (Begley et al., 2006); this is the first step in 
bacterial conversion of bile (Joyce and Gahan, 2016). Of note, lactobacilli also tended to be 
decreased in the BTBR gut (Table S2). Unconjugated primary BAs are further transformed into 
secondary BAs as a result of 7α-dehydroxylation activity, which is present in some members of 
Clostridium cluster XIVa including Blautia species (Ridlon et al., 2013). Therefore, a substantial 
loss in Blautia and Bifidobacterium species in the BTBR microbiota strongly suggest that the 
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efficacy of bacteria-mediated bile transformation, as well as the effect of bacteria on 5-HT 
production are impaired in the BTBR intestine.  
The follow-up analysis of bile moieties and tryptophan metabolites in the BTBR gut confirmed 
the sequencing-based functional predictions. First, we observed a dramatic increase in all 
conjugated BAs, as well as a reduction in secondary BA pool in BTBR fecal matter (Fig 5d and 
Fig S3). These data indicate that both bile salt hydrolase and 7α-dehydroxylation activities are 
compromised in the BTBR microbiota. Secondly, we found a marked reduction in 5-HT 
bioavailability in BTBR small and large intestine due to a decrease in 5-HT synthesis and an 
increase in 5-HT breakdown (Fig 2e-f). Strikingly, intestinal 5-HT levels and Tph1 gene 
expression were strongly and positively correlated with the relative abundance of Blautia genus 
(Fig 2g, Table S3). Hence, the observed reduction in the abundance of Blautia species could 
underlie the deficit in 5-HT production in the BTBR gut. 
Changes in either tryptophan metabolism or the microbial conversion of bile can have a 
tremendous impact on GI physiology. Secondary BAs, produced by gut bacteria, have a unique 
signaling profile in the GI tract as compared with primary bile moieties. For example, secondary 
BAs were shown to activate colonic motility by stimulating the release of intestinal 5-HT and 
CGRP (Alemi et al., 2013). Therefore, a reduction in secondary BA levels could contribute to the 
delayed colonic transit in BTBR mice (Fig 2b-d). Further, tauro-conjugated β-MCA has recently 
been shown to be a potent natural antagonist of Fxr receptor in mice and to inhibit its 
downstream signaling (Sayin et al., 2013). Hence, an increase in Tβ-MCA intestinal levels in 
BTBR mice can explain the observed down-regulation of Fgf15 gene expression in the BTBR 
ileum (Fig 5b and d). In addition to the deficits in bacteria-mediated bile conversion, BTBR mice 
displayed a reduction in plasma BA levels, most likely due to a decrease in BA synthesis along 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IPT
 21 
the classical Cyp7a1-mediated pathway (Fig 5a and c). This can have deleterious consequences 
for the intestine as well. BAs are toxic for many bacterial species; they also induce the 
expression of anti-microbial defense genes in the host (including iNOS, RegIIIγ) (Inagaki et al., 
2006; Joyce et al., 2014). In fact, a reduction in the luminal BA levels has been associated with 
small intestine bacterial overgrowth, activation of inflammation, and subsequent damage to the 
epithelium (Inagaki et al., 2006; Lorenzo-Zúñiga et al., 2003). A down-regulation of iNos (Nos2) 
gene expression in the ileum of BTBR mice (Fig 5b) suggests that anti-microbial defense can be 
compromised in the BTBR intestine, which in turn could contribute to the impairment of small 
intestine barrier function (Fig 4a). 
Similar to bile moieties, tryptophan metabolites are involved in the regulation of essential GI 
functions. 5-HT activates intestinal peristalsis and electrolyte secretion, supports the 
development of the ENS and amplifies inflammatory responses in the gut (Ghia et al.; Heredia et 
al., 2013; Liu et al., 2009; Mawe and Hoffman, 2013). Hence, a decrease in 5-HT bioavailability 
can explain delayed intestinal transit and reduced activity of electrolyte transport seen in BTBR 
mice (Fig2a-d, Fig 4f). Interestingly, metabolism of tryptophan along the kynurenine route also 
seems to be affected in BTBR mice. The expression levels of Ido1 and Tdo2 genes, which 
encode alternative rate-limiting enzymes in this pathway, were markedly altered in the BTBR 
intestine (Fig 2e-f). Tdo2 gene expression is responsive to stress and is under a tight control of 
glucocorticoids (Green and Curzon, 1975). Strikingly, we found an increased expression of 
Cyp11a1 gene in the BTBR ileum (Fig S2b), which could have resulted in elevated production of 
corticosterone and an up-regulation of Tdo2 locally in the BTBR ileum (Fig 2f). The observed 
changes in intestinal Ido1 and Tdo2 gene expression are very unlikely to have a direct effect on 
the brain in BTBR mice. Indeed, more than 90% of tryptophan is catabolized down to 
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kynurenine in the liver, with liver Tdo2 activity determining the systemic levels of kynurenine, 
and the availability of tryptophan for the brain (Kennedy et al., 2017). To this end, neither the 
expression of liver Tdo2 nor the plasma levels of tryptophan was altered in BTBR mice (Fig S5a-
b). However, this will certainly affect the intestinal levels of kynurenine and its metabolites 
(kynurenic and quinolinic acids), and local effects on the BTBR gut physiology are thus very 
plausible. For instance, kynurenic acid is known to slow down the intestinal transit by inhibiting 
the enteric NMDA receptors, as well as to dampen the inflammatory response in the gut (Érces et 
al., 2012; Kaszaki et al., 2008; Keszthelyi et al., 2009). Moreover, both 5-HT and kynurenine 
metabolites can alter the activity of intestinal vagal afferents, and hence, might directly affect 
vagal signaling to the brain (Slattery et al., 2006). Of note, recent evidence suggests altered 5-HT 
and kynurenine metabolism in ASD (Boccuto et al., 2013; Lim et al., 2015; Muller et al., 2016). 
Altered tryptophan metabolism and inadequate bacterial conversion of bile are thus very likely to 
contribute to both intestinal dysmotility and impaired gut barrier function in BTBR mice. 
Maintenance of epithelial integrity is critically important not only for gut health, but also for 
brain health. The phenomenon of “leaky” gut has recently been extended beyond GI disorders, 
such as irritable bowel syndrome, to psychiatric diseases, such as depression (Kelly et al., 2015). 
Dysfunctional intestinal barrier in BTBR mice can permit the microbiota to induce low-grade 
inflammation in the gut. This shift towards a pro-inflammatory state, particularly in combination 
with an anxious phenotype (Fig 6h-l), can in turn trigger the activation of neuroinflammatory 
responses in the brain (Rea et al., 2016; Wohleb et al., 2015) and exaggerate autistic-like 
behavioral deficits in BTBR mice. Indeed, the BTBR mouse has been shown to display a pro-
inflammatory phenotype that is thought to contribute to the development of ASD-like behavior 
(Careaga et al., 2015; Heo et al., 2011; Onore et al., 2013). Interestingly, we found that deficits 
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in social behavior in BTBR mice were accompanied by a decrease in plasma oxytocin levels (Fig 
6d). Oxytocin is one of the key hormones involved in supporting the salience of social 
interactions, and is known to be modulated by intestinal microbiota (Buffington et al., 2016; 
Varian et al., 2017).  
In summary, here we show that the BTBR mouse displays marked GI dysfunction (Fig 8). 
Similar to human ASD, BTBR mice have “leaky” intestinal epithelium and delayed intestinal 
transit. We further identify deficient bacterial transformation of bile moieties and impaired 
tryptophan metabolism in the BTBR intestine as potential mechanisms underlying GI symptoms 
in these animals. Taking advantage of microbiota sequencing and physiological data, we 
associate these functional changes with a reduction in the relative abundance of Bifidobacterium 
and Blautia bacteria in the BTBR microbiota. These data offer specific targets in the gut 
microbiota for improving gastrointestinal and, perhaps, behavioral symptomatology in the BTBR 
mouse model of autism, and support the concept of microbiota-based interventions in ASD. 
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Figure Legends 
Figure 1. Altered microbiota composition and short chain fatty acid levels in BTBR mice 
(a-b) BTBR cecal microbiota showed lower diversity of bacterial species, and was clearly 
separated from the microbiota of C57BL/6 mice. (c) Heatmap of log2 fold change ratio showing 
increases (red) or decreases (blue) in most abundant bacteria in BTBR compared to C57BL/6 
mice. Significant changes are bolded (for details, see Table S2). (d) Short chain fatty acid cecal 
levels were differentially changed in BTBR mice. *p<0.05 for BTBR vs. C57BL/6 group. 
Statistical analysis: data are presented as median with IQR and min/max values as error bars on (a), and as mean + SEM on (d). 
N=9 for C57BL/6 and N=10 for BTBR group. U(17)=0.000, p<0.0005 for Chao1 index;  U(17)=15.5, p=0.013 for Simpson index;  
U(17)=0.000, p<0.0005 for Shannon index; U(17)=0.000, p<0.0005 for No of species, Mann-Whitney test. t(17)=2.424, p=0.027 for 
acetate; t(17)=-0.265, p=0.794 for propionate; t(17)=-2.887, p=0.010 for n-butyrate; t(17)=4.023, p=0.001 for i-butyrate, unpaired t-
test.  
 
Figure 2. Delayed intestinal transit and impaired serotonin metabolism in BTBR mice: 
implication of microbiota (a-c) BTBR mice showed delayed whole intestinal transit, as well as 
an elongated colon and decreased fecal water contents. (d) Colonic transit was impaired in 
BTBR mice. (e-f) Serotonin (5-HT) tissue levels were reduced in both small and large intestine 
of BTBR mice. This was coupled with alterations in the expression of genes involved in 
tryptophan metabolism. (g) Intestinal transit rate and 5-HT levels were strongly associated with 
the relative abundance of Blautia bacteria (see also Table S2). *p<0.05 for BTBR vs. C57BL/6 
group. Statistical analysis: data are presented as mean + SEM; n=8 for C57BL/6 and n=6 for BTBR group  for (d), n=9-10 in 
either group for the rest. t(18)=-4.524, p<0.0005 for the intestinal transit time; t(18)=-14.053, p<0.0005 for the colon length; t(12)=-
4.107, p=0.001 for the latency to initiate propagation; t(11)=1.599, p=0.138 for the propulsive activity; t(17)=3.597, p=0.002 for 5-
HT levels and t(15)=-1.814, p=0.09 for 5-HT/5-HIAA ratio in the colon; t(17)=5.069, p<0.0005 for Tph1, t(18)=1.928, p=0.070 for 
P11, t(16)=4.578, p=0.003 for Ido1, t(18)=3.835, p=0.006 for Tdo2 and t(18)=-4.851, p<0.0005 for Sert gene expression in the colon; 
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t(17)=4.164, p=0.001 for 5-HT levels and t(8)=-0.930, p=0.380 for 5-HT/5-HIAA ratio in the ileum; t(17)=2.311, p=0.034 for Tph1, 
t(17)=2.533, p=0.021 for P11, t(16)=9.546, p<0.0005 for Ido1, t(18)=-14.655, p<0.0005 for Sert and t(18)=-2.739, p=0.013 for Tdo2 
gene expression in the ileum, unpaired t-test. Spearman’s rho was employed for the correlation analysis in the pooled datasets. 
 
Figure 3. BTBR mice display deficits in the development of the enteric nervous system (a) 
Anti-ChAT staining (green) in whole mount preparations of distal colon revealed the fine 
structure of myenteric plexus (MP), with ganglia and interconnecting fibers. Cellular nuclei were 
stained with DAPI (blue). (b) The spatial density of MP was decreased in BTBR mice. (c) 
Myenteric ganglia were co-stained against pan-neuronal marker HuC/HuD (green) and nNOS 
(red). (d) BTBR mice showed a reduction in total and nNOS-positive neuronal numbers. Scale 
bar represents 100 μm *p<0.05 for BTBR vs. C57BL/6 group. Statistical analysis: data are presented as 
median with IQR and min/max values as error bars; n=5 in either group. U(9)=0.000, p=0.004 for MP area; U(9)=30.000, p=0.004 
for interganglionic space; U(9)=6.000, p=0.126 for MP contact ratio; U(9)=5.000, p=0.082 for MP thickness; U(8)=0.000, p=0.008 
for HuC/HuD neurons; U(8)=0.000, p=0.008 for nNOS neurons, Mann-Whitney test. 
 
Figure 4. Differential changes to epithelial permeability and tight junction-associated gene 
expression in small and large intestine of BTBR mice  (a) In distal ileum, BTBR mice showed 
a marked increase in FITC transepithelial permeability, with no substantial changes to either 
tight junction-associated genes (b) or mucin2 gene expression (e). (c) In the colon of BTBR 
mice, FITC permeability was increased in the end, but decreased in the beginning of the 
incubation period. The biphasic response of FITC flux was coupled with an up-regulation of 
tight junction protein genes expression, but a down-regulation of creatine kinase and mucin2 
genes (d-e). (f) TEER was not changed, while Isc was substantially decreased in the BTBR 
intestine. *p<0.05 for BTBR vs. C57BL/6 group. Statistical analysis: data are presented as mean + SEM , n=10 
in either group. FITC permeability in distal ileum: F(6;84)=63.339, p<0.0005 for the effect of Time, F(1;14)=7.090, p=0.019 for the 
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effect of Genotype, F(6;84)=7.177, p=0.015 for the Time x Genotype interaction. FITC permeability in the colon: F(6;102)=383.858, 
p<0.0005 for the effect of Time, F(1;17)=0.061, p=0.808 for the effect of Genotype, F(6;102)=9.198, p=0.002 for the Time x 
Genotype interaction. Datasets were analyzed with mixed-design ANOVA with Genotype as an independent factor and Time as a 
repeated measure. Mean values in each time point were further comp ared between groups with unpaired t-test. t(14)=1.582, 
p=0.136 for TEER; t(14)=6.862, p<0.0005 for Isc; t(18)=0.624, p=0.541 for Cldn1, t(18)=-1.429, p=0.170 for Ocln, t(18)=-2.768, 
p=0.013 for Tjp1, t(15)=-3.292, p=0.005 for Ckb, t(16)=-3.731, p=0.002 for Ckm, t(15)=0.217, p=0.831 for Mylk, t(17)=1.278, p=0.218 
for Muc2 gene expression in distal ileum, unpaired t-test. t(18)=1.101, p=0.285 for TEER; t(18)=4.407, p=0.001 for Isc; t(18)=-6.319, 
p<0.0005 for Cldn1, t(18)=-2.273, p=0.035 for Ocln, t(18)=0.104, p=0.918 for Tjp1, t(17)=4.791, p<0.0005 for Ckb, t(17)=3.255, 
p=0.005 for Ckm, t(17)=5.751, p<0.0005 for Mylk, t(17)=6.261, p<0.0005 for Muc2 gene expression in the colon, unpaired t-test.  
  
Figure 5. Altered bile acid signatures and deficient bacterial metabolism of bile moieties in 
BTBR mice (a) In plasma, a reduction in unconjugated and tauro-conjugated BA levels was seen 
in BTBR mice. (b-c) The gene expression levels of BA transporters were not altered in the distal 
ileum or liver of BTBR mice. In contrast, Cyp7a1 and Pparg genes in the liver, as well as Fgf15 
and Nos2 genes in the ileum were down-regulated in BTBR mice. (d) In the fecal matter of 
BTBR mice, a dramatic increase in all tauro-conjugated BAs, and a trend towards a reduction in 
unconjugated secondary BAs were observed. *p<0.05 for BTBR vs. C57BL/6 group. Statistical 
analysis: data are presented as median with IQR and min/max values as error bars on (a) and (d), and as mean + SEM on (b) and 
(c). U(11)=11.000, p=0.181 for total BAs, U(11)=7.000, p=0.051 for CA, U(11)=2.000, p=0.005 for CDCA, U(11)=19.000, p=0.836 
for β-MCA, U(10)=1.500, p=0.005 for DCA, U(11)=25.000, p=0.628 for LCA, U(11)=0.000, p=0.001 for UDCA, U(10)=10.000, 
p=0.268 for total TBAs, U(10)=13.000, p=0.530 for TCA, U(10)=5.000, p=0.048 for TCDCA, U(10)=8.000, p=0.149 for Tβ-MCA, 
U(10)=10.000, p=0.268 for TDCA, U(10)=27.000, p=0.149 for TLCA, U(10)=2.000, p=0.010 for TUDCA levels in plasma, n=7 in 
C57BL/6 and n=6 in BTBR group, Mann-Whitney test. U(11)=16.000, p=0.534 for total BAs, U(11)=25.000, p=0.628 for CA, 
U(11)=17.000, p=0.628 for CDCA, U(11)=34.000, p=0.073 for β-MCA, U(11)=10.000, p=0.138 for DCA, U(11)=6.000, p=0.035 for 
LCA, U(11)=10.000, p=0.138 for UDCA, U(11)=39.000, p=0.008 for total TBAs, U(11)=35.000, p=0.051 for TCA, U(11)=37.000, 
p=0.022 for TCDCA, U(11)=38.000, p=0.014 for Tβ-MCA, U(11)=40.000, p=0.005 for TDCA, U(11)=39.000, p=0.008 for TLCA, 
U(11)=42.000, p=0.001 for TUDCA levels in the fecal matter, n=7 in C57BL/6 and n=6 in BTBR group, Mann-Whitney test. 
t(18)=-0.081, p=0.936 for Fxr, t(18)=-0.488, p=0.632 for Rxra, t(18)=-0.726, p=0.477 for Hnf4a, t(17)=2.776, p=0.013 for Fgf15, 
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t(18)=2.807, p=0.012 for Nos2, t(18)=-0.102, p=0.920 for Asbt, t(18)=-0.373, p=0.714 for Fabp6, t(18)=-0.118, p=0.907 for Osta gene 
expression in distal ileum, n=10 in either group, unpaired t-test. t(11)=1.887, p=0.086 for Cyp7a1, t(12)=-3.157, p=0.008 for 
Cyp7b1, t(12)=-0.274, p=0.788 for Fxr, t(12)=-0.905, p=0.383 for Rxra, t(12)=-0.525, p=0.609 for Hnf4a, t(11)=3.189, p=0.009 for 
Pparg, t(12)=2.190, p=0.061 for Pgc-1a, t(12)=0.167, p=0.870 for Ntcp, t(12)=-0.274, p=0.788 for Bsep gene expression in the liver, 
n=8 in C57BL/6 and n=6 in BTBR group, unpaired t-test. 
 
Figure 6. Autistic-like behavioral phenotype in BTBR mice (a-d) BTBR mice displayed 
impaired social interactions, as well as decreased plasma levels of oxytocin. (e-f) BTBR mice 
were largely engaged in compulsive behaviors. They showed impaired working memory 
performance (g), enhanced locomotor activity and anxiety-like behavior (h, i and k). (j) No 
evidence of depressive-like behavior was observed. (l) BTBR mice displayed elevated plasma 
corticosterone levels at baseline and when being exposed to an acute stressor (forced swim test). 
(m-n) BTBR mice had smaller adrenal glands and increased expression of glucocorticoid 
receptor gene in the hippocampus. *p<0.05 for BTBR vs. C57BL/6 group. Statistical analysis: data are 
presented as median with IQR and min/max values as error bars on (e) and (k), and as mean + SEM on the rest, n=10 in either 
group. t(18)=8.153, p<0.0005 for Mouse vs Object and t(17)=3.707, p=0.002 for Novel vs Familiar Mouse preference; t(18)=5.678, 
p<0.0005 for the RI interaction;  t(13)=3.485, p=0.004 and t(13)=2.029, p=0.063 for the cued food preference at 0h and 24h time 
points, respectively; t(17)=3.623, p=0.002 for oxytocin levels; t(18)=-6.303, p<0.0005 for self-grooming time; t(18)=3.040, p=0.011 
for the NOR discrimination index; t(18)=0.059, p=0.953 for the time in the center, t(18)=-2.090, p=0.051 for the latency to enter the 
center and t(18)=-7.099, p<0.0005 for the distance travelled in the OF test; t(17)=2.947, p=0.009 for open arm entries in the EPM 
test; t(18)=2.785, p=0.012 for the immobility time in the FST test; t(18)=3.229, p=0.005 for the adrenal glands weight; t(17)=-5.480, 
p<0.0005 for the Gr and t(17)=-1.845, p=0.094 for the Mr gene expression, unpaired t-test. U(18)=83.000, p=0.011 for # of buried 
marbles; U(18)=99.000, p<0.0005, U(18)=98.000, p<0.0005 and U(18)=83.000, p=0.001 for  # of fecal pellets in the OF, NOR and 
EPM tests, respectively, Mann-Whitney test. Plasma Corticosterone: F(5;80)=209.091, p<0.0005 for the effect of Time, 
F(1;16)=8.193, p=0.011 for the effect of Genotype, F(5;80)=1.534, p=0.221 for the Time x Genotype interaction. Datasets were 
analyzed with mixed-design ANOVA with Genotype as an independent factor and Time as a repeated measure. Mean values in 
each time point were further compared between groups with unpaired t-test. 
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Figure 7. A strong association between behavioral scores and gut microbiota composition A 
correlation matrix showing positive (red) and negative (blue) associations between behavioral 
scores and the relative abundance of bacterial genera in BTBR and C57BL/6 mice. Significant 
correlations are marked with asterisks. *p<0.05, **p<0.01 and ***p<0.001, Spearman’s rank 
correlation analysis, Benjamini-Hochberg adjusted p value with a FDR of 0.05.  
 
Figure 8. Putative mechanisms linking changes in the gut microbiota with GI malfunction 
in the BTBR mouse model of human ASD. In BTBR mice, autistik-like behavioural phenotype 
is associated with altered microbiota and marked GI distress: increased epithelial permeability 
(1) and delayed intestinal motility (2). (1) Reduced abundance of bile-metabolising 
Bifidobacterium  species increases the fraction of tauro-conjugated BAs (e.g. tauromuricholic 
acid (TβMCA)) in the GI tract. TβMCA inhibits Fxr signaling and thus supresses anti-microbial 
defense of the host (iNOS, RegIIIγ). We hypothesise that the loss of Fxr signaling in BTBR mice 
causes small intestinal bacterial overgrowth and, as a result, an increase in epithelial 
permeability. This effect is further exaggerated by deficient synthesis of BAs, which normally 
prevent bacterial overgrowth. (2) Healthy intestinal transit relies on many factors, including the 
ENS, secondary BAs and 5-HT (all deficient in BTBR mice). Secondary BA levels are reduced; 
5-HT bioavailability is decreased due to a lower production (down-regulation of Tph1) and a 
higher breakdown (up-regulation of Sert) rates. Lower abundance of clostridia bacteria, 
including Blautia species, potentially contributes to these changes. Further, the BTBR myeneric 
plexus shows reduced numbers of excitatory and inhibitory neurons. All this can cause delayed 
intestinal motility in BTBR mice. 
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